Texas Permanent School Fund’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-73,562
| Closed | -$280K | – | 1533 |
|
|
2020
Q1 | $280K | Buy |
73,562
+14,449
| +24% | +$55K | 0.01% | 1374 |
|
|
2019
Q4 | $301K | Buy |
59,113
+291
| +0.5% | +$1.48K | ﹤0.01% | 1437 |
|
|
2019
Q3 | $297K | Buy |
58,822
+1,309
| +2% | +$6.61K | ﹤0.01% | 1415 |
|
|
2019
Q2 | $355K | Buy |
57,513
+110
| +0.2% | +$679 | 0.01% | 1390 |
|
|
2019
Q1 | $266K | Buy |
57,403
+2,079
| +4% | +$9.63K | ﹤0.01% | 1449 |
|
|
2018
Q4 | $232K | Buy |
55,324
+2,565
| +5% | +$10.8K | ﹤0.01% | 1446 |
|
|
2018
Q3 | $331K | Buy |
52,759
+5,180
| +11% | +$32.5K | ﹤0.01% | 1434 |
|
|
2018
Q2 | $383K | Buy |
47,579
+1,059
| +2% | +$8.53K | 0.01% | 1420 |
|
|
2018
Q1 | $347K | Sell |
46,520
-980
| -2% | -$7.31K | ﹤0.01% | 1412 |
|
|
2017
Q4 | $283K | Sell |
47,500
-3,800
| -7% | -$22.6K | ﹤0.01% | 1454 |
|
|
2017
Q3 | $378K | Buy |
51,300
+28
| +0.1% | +$206 | ﹤0.01% | 1414 |
|
|
2017
Q2 | $348K | Buy |
51,272
+954
| +2% | +$6.48K | ﹤0.01% | 1420 |
|
|
2017
Q1 | $475K | Buy |
+50,318
| New | +$475K | 0.01% | 1338 |
|